Salvatore Salomone

Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.

Journal: The Cochrane database of systematic reviews

Published: November 24, 2022

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.

Journal: The Cochrane database of systematic reviews

Published: August 30, 2022

Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions.

Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions.

Journal: Brain, behavior, and immunity

Published: July 11, 2022

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders.

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders.

Journal: Brain sciences

Published: June 15, 2022

Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications.

Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: June 06, 2022

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021.

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021.

Journal: Frontiers in pharmacology

Published: February 07, 2022

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Journal: Frontiers in pharmacology

Published: November 05, 2021

Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice.

Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice.

Journal: International journal of molecular sciences

Published: April 19, 2021

Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta.

Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta.

Journal: Biomolecules

Published: February 13, 2021

Genomic Portrait of a Sporadic Amyotrophic Lateral Sclerosis Case in a Large Spinocerebellar Ataxia Type 1 Family.

Genomic Portrait of a Sporadic Amyotrophic Lateral Sclerosis Case in a Large Spinocerebellar Ataxia Type 1 Family.

Journal: Journal of personalized medicine

Published: November 06, 2020

Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments.

Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 11, 2020

Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.

Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: September 25, 2020

Showing 1-12 of 102

Last Updated: 09/26/2026